Biopharmaceutical News and Research

RSS
CytoDel successfully delivers neuronal antibody in animal models of botulism

CytoDel successfully delivers neuronal antibody in animal models of botulism

RedHill Biopharma: RHB-204 receives FDA Fast Track designation for treatment of NTM disease

RedHill Biopharma: RHB-204 receives FDA Fast Track designation for treatment of NTM disease

FDA takes first steps in bringing clarity to emerging area of individualized drug development

FDA takes first steps in bringing clarity to emerging area of individualized drug development

P2 COVID-19 study shows no material safety differences between opaganib and control arms

P2 COVID-19 study shows no material safety differences between opaganib and control arms

Phase 2/3 COVID-19 study evaluates safety, potential identification of preliminary efficacy signals

Phase 2/3 COVID-19 study evaluates safety, potential identification of preliminary efficacy signals

Novel SARS-CoV-2 neutralizing antibody enters Phase 1/2a clinical study

Novel SARS-CoV-2 neutralizing antibody enters Phase 1/2a clinical study

RedHill Biopharma announces promising preliminary results from opaganib study

RedHill Biopharma announces promising preliminary results from opaganib study

Phase 2 clinical trial at UCR to test first-in-class drug for treatment of stuttering

Phase 2 clinical trial at UCR to test first-in-class drug for treatment of stuttering

Researchers develop new technology for efficient production of monoclonal antibodies

Researchers develop new technology for efficient production of monoclonal antibodies

£453,000 grant awarded to boost research and development for COVID-19 antibodies

£453,000 grant awarded to boost research and development for COVID-19 antibodies

Takeda brings innovative pipeline portfolio to patients for sustained revenue growth

Takeda brings innovative pipeline portfolio to patients for sustained revenue growth

FUJIFILM Irvine Scientific launches Sterile Express Media Service

FUJIFILM Irvine Scientific launches Sterile Express Media Service

Nanomedicine's giant step into the fight against the COVID-19

Nanomedicine's giant step into the fight against the COVID-19

Marinomed plans a clinical trial with Carragelose nasal spray as COVID-19 prophylaxis

Marinomed plans a clinical trial with Carragelose nasal spray as COVID-19 prophylaxis

Novel CAR T-cell therapy shows promising early results in children with neuroblastoma

Novel CAR T-cell therapy shows promising early results in children with neuroblastoma

COVID-19 vaccine candidate tested preclinically at UAB poised for Phase 1 clinical study

COVID-19 vaccine candidate tested preclinically at UAB poised for Phase 1 clinical study

Marinomed to initiate clinical trial with Carragelose for preventing COVID19 in frontline healthcare staff

Marinomed to initiate clinical trial with Carragelose for preventing COVID19 in frontline healthcare staff

Oxford University and AstraZeneca release their COVID-19 vaccine results

Oxford University and AstraZeneca release their COVID-19 vaccine results

Sinovac Biotech's COVID-19 vaccine candidate triggers immune response

Sinovac Biotech's COVID-19 vaccine candidate triggers immune response

Promising new compounds to potentially treat novel coronaviruses identified

Promising new compounds to potentially treat novel coronaviruses identified